Trial Profile
EvaluaTion of Clinical and laboratory outcomes of Rivaroxaban in short Bowel syndrome patients dEpending on Long term parenteral nutrition: a prospective cohort study (TINCRBEL study)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2019
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Stroke; Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms TINCRBEL study
- 24 Jul 2018 New trial record